Alternative Medicine As an Effective Migraine Treatment
Statistics indicate that we now have over 100,000 Americans who're suffering from TS (Tourette's syndrome). This complex neuropsychiatric disorder that is certainly seen as involuntary vocal tics is of unknown etiology. While the seriousness of this problem varies widely among patients, research indicates how the condition usually improves with age. Currently, there is no cure for Tourette's syndrome. However, research indicates that medical cannabis may help people deal with the symptoms as the medical marijuana doctors state.
Crohns Disease - Various studies show promising most current listings for medicinal marijuana alleviating the symptoms of gastrointestinal disorders such as Crohn's. Marijuana contains cannabinoids which activate a receptor called CB2 - this is considered to decrease inflammation in the GI tract as well as reducing pain and swelling.
How does the Arizona Medical Marijuana Act affect employers? Employers cannot discriminate against a person in hiring, terminating or imposing any term or condition of employment or else penalize an individual based on either; (1) the person's status like a cardholder, or (2) a registered qualifying patient's positive drug test for marijuana components or metabolites, unless the patient used, possessed or was impaired by marijuana about the premises in the where you work or throughout the hours of employment.
With all these limitations, science was not spared. Research on medicinal marijuana is extremely limited and studies offering the consequences of medicinal marijuana use on already terminally ill patients are minimal. Large pharmaceutical companies don't research a plant that creates something will either be very costly being a final product and won't sell well enough, or worse, will not even get final approval from institutions just like the FDA. Add to that this sky-high tariff of the experiments required to reach scientific facts and you obtain a final "No" from nearly all research center and pharmaceutical company. However, as a result of known that people used this plant and have took advantage of it greatly, it would be an unjustifiable bias to limit or discontinue research.
In 2002, a placebo-controlled randomized study that investigated the use of Cesamet (a synthetic oral cannabinoid naboline) in 15 patients afflicted with segmental primary and generalized dystonia showed no significant improvement of their condition. Investigators concluded that this outcome may be dose related possesses nothing to do with the efficacy of medical cannabis in aiding patients manage their dystonia symptoms. High doses with the natural non-psychoactive CBD (cannabinoid cannabidiol) and synthetic cannabinoids are acknowledged to moderate the progression with the disease in animals as indicated by a minumum of one recent preclinical trial and further investigation regarding the use of cannabis and cannabinoids in humans is underway.
